CPO
NVO

Cerity Partners OCIO’s Novo Nordisk NVO Stock Holding History

Cerity Partners OCIO’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$332K Buy
4,910
+334
+7% +$19.6K 0.01% 362
2022
Q3 		$228K Buy
4,576
+300
+7% +$16.1K 0.01% 387
2022
Q2 		$238K Buy
+4,276
New +$237K 0.01% 379

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Cerity Partners OCIO's NVO Position: Q4 2022 in Review

Cerity Partners OCIO increased its Novo Nordisk (NVO) stake by 7.3% in Q4 2022, buying an estimated $19.6K and bringing the position to 4,910 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #362.

Cerity Partners OCIO first reported a position in NVO in Q2 2022 and has held it in 3 quarters since. 1,049 funds tracked by Wall St. Rank hold NVO as of Q4 2022.

  • Cerity Partners OCIO held 4,910 shares of Novo Nordisk worth $332K as of Q4 2022.
  • Cerity Partners OCIO bought 334 Novo Nordisk shares in Q4 2022, an estimated $19.6K.
  • Novo Nordisk made up 0.01% of Cerity Partners OCIO's portfolio in Q4 2022, its #362 holding.
  • Cerity Partners OCIO first reported a position in Novo Nordisk in Q2 2022 and has held it in 3 quarters since.
  • 1,049 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2022.

Based on Cerity Partners OCIO's 13F filing for Q4 2022, filed 2 Feb 2023.